Verona, NJ, United States of America

Fernando Padilla

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Verona, NJ (US) (2014 - 2018)
  • Ann Arbor, MI (US) (2018 - 2020)

Company Filing History:


Years Active: 2014-2020

Loading Chart...
Loading Chart...
10 patents (USPTO):

Title: The Innovative Contributions of Fernando Padilla

Introduction

Fernando Padilla is a notable inventor based in Verona, NJ (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 10 patents, Padilla has focused on developing novel compounds that address various medical disorders.

Latest Patents

Among his latest patents, Padilla has developed indazolyl-1,2,4-thiadiazolamines and related compounds aimed at inhibiting Rho-associated protein kinase. This invention provides pharmaceutical compositions and methods for treating inflammatory disorders, immune disorders, fibrotic disorders, and other medical conditions. An exemplary compound from this patent is an N-(3-(5-((1H-indazol-5-yl)amino)-1,2,4-thiadiazol-3-yl)phenyl)-heteroaryl-carboxamide. Additionally, he has worked on inhibitors of SYK, which are useful for treating autoimmune and inflammatory diseases.

Career Highlights

Throughout his career, Padilla has been associated with prominent companies such as Hoffmann-La Roche Inc. and Lycera Corporation. His work in these organizations has contributed to advancements in medical research and drug development.

Collaborations

Padilla has collaborated with notable professionals in his field, including Matthew C. Lucas and Johannes Cornelius Hermann. These collaborations have further enhanced his innovative efforts in pharmaceutical research.

Conclusion

Fernando Padilla's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the treatment of various medical disorders, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…